Introduction phase transition (Irniger et al., 1995) . The APC is regulated by phosphorylation and is Eukaryotic cell division is controlled by members of the active from anaphase until Start, corresponding to the cyclin-dependent kinase (Cdk) family. Cdk activity is window of mitotic cyclin instability in yeast (Amon et al., subject to regulation by phosphorylation, association 1994) . with positive regulatory subunits known as cyclins, and Selective proteolysis is central to the events that conbinding to Cdk inhibitor proteins (reviewed by Pines, stitute the Start decision in late G1 phase. Elaboration 1995). The budding yeast Saccharomyces cerevisiae of Clb5/Clb6-Cdc28 activity and the initiation of DNA has a single essential Cdk (called Cdc28 or Cdk1) that replication is contingent on the elimination of a Clbcatalyzes entry into a new division cycle in late G1 phase Cdc28 inhibitor called p40 SIC1 (Mendenhall, 1993; Nugroho and Mendenhall, 1994) , which holds Clb5/Clb6-Cdc28 in check until cells have passed Start. 7 Present address: Eli Lilly Canada Inc., 3650 Danforth Avenue, Scarborough, Ontario, Canada M1N 2E8.
Phosphorylation of p40
SIC1 by the Cln-Cdc28 kinases at Start may target p40 SIC1 for ubiquitination by the Cdc34 To allow specific detection of Cln2-associated proteins, ubiquitin-conjugating enzyme (Schwob et al., 1994;  we used a CLN2 allele that was tagged with a triple Schneider et al., 1996; Tyers, 1996) . Two other proteins, influenza hemagglutinin (HA) epitope recognized by the Cdc4 and Cdc53, are also implicated in the degradation 12CA5 monoclonal antibody (Tyers et al., 1993) . To maxof p40 SIC1 because, like cdc34 mutants, cdc4 and cdc53 imize the likelihood of identifying G1-specific proteins, mutants arrest with unreplicated DNA and multiple elonwe overexpressed CLN2 HA from the ADH1 promoter in gated buds (Yochem and Byers, 1987; Goebl et al., 1988;  a cdc34-2 strain arrested at the nonpermissive temperaMathias et al., submitted). Recently, a protein called ture in late G1 phase when Cln2 abundance and Cln2-Skp1 has been shown to interact directly with Cdc4 and Cdc28 kinase activity are maximal (Wittenberg et al. , to be necessary for p40 SIC1 proteolysis (Bai et al., 1996) . 1990; Tyers et al., 1993) . Proteins retained on 12CA5 In addition to catalyzing cell cycle transitions, protein antibody columns from the CLN2 HA lysate, but not from degradation is critical for the proper integration of Cdk an untagged control lysate, were identified by SDSactivity with environmental signals. Usually this integrapolyacrylamide gel electrophoresis (SDS-PAGE) (Figure tion occurs in G1 phase, whether it be nutrient sensing 1A). The validity of this approach was established by in yeast or growth factor signaling in mammalian cells the specific retention of two proteins known to interact (reviewed by Sherr, 1994) . Cln1, Cln2, and Cln3 are highly with Cln2. Cdc28, the cognate Cdk for Cln2 (Wittenberg unstable proteins, a characteristic that is essential for et al., 1990) , was identified as a predominant 34 kDa the coordination of Start with nutrient availability and species among the retained proteins by immunoblotting the presence of mating pheromones. In part, these enviwith anti-Cdc28 antibody (data not shown). Cks1, a small ronmental cues repress CLN transcription, and this protein known to bind Cdc28 complexes (Hadwiger et leads to G1 arrest because Cln proteins are rapidly deal., 1989a) , was identified by direct microsequencing of pleted. For instance, CLN1 is repressed by glucosea 21 kDa polypeptide in Cln2 HA eluates (data not shown). mediated activation of the Ras/cAMP pathway, and this A prominent species of 94 kDa was also specifically accounts for a cell cycle delay at Start (Baroni et al., retained from a Cln2 HA lysate, but not from an untagged 1994; . Conversely, mutations that control lysate ( Figure 1A ). Microsequencing of peptides stabilize Cln proteins, such as CLN2-1, CLN2
4T3S
, and derived from this band yielded 14 internal peptide se-CLN3-1, confer resistance to mating pheromone and quences. A search of a private database maintained nutrient arrest (Cross, 1988; Nash et al., 1988;  Hadwiger by M. Goebl (Indiana University College of Medicine) et al., 1989b; Lanker et al., 1996) . The determinants for revealed that 11 of the peptide sequences matched the Cln instability were first defined by the CLN2-1 and amino acid sequence deduced from the CDC53 gene CLN3-1 mutations, which encode truncated proteins ( Figure 1B ), which had been cloned previously (M. Goebl, that lack carboxy-terminal PEST sequences. Such sepersonal communication; Mathias et al., submitted). quences often occur in unstable proteins (Rogers et al., The complex containing Cdc53 and Cln2 was not re-1986) and are also present in human G1 cyclins (Lew et stricted to cells arrested by the cdc34-2 mutation, since al., 1991). Recently, phosphorylation of specific Cdc28
Cdc53 was identified in 12CA5 column eluates from consensus sites in the carboxyl terminus of Cln2 and asynchronous wild-type cultures expressing pADH1-Cln3 has been implicated in Cln instability (Yaglom et CLN2 HA ( Figure 1C ). In this experiment, small-scale anaal., 1995; Lanker et al., 1996) . In particular, a mutant lytical columns were used, and Cdc53 was detected version of Cln2 that lacks seven Cdc28 consensus phosby immunoblotting with polyclonal antibodies directed phorylation sites is hyperstable and causes deregulation against Cdc53. The Cln2-Cdc53 complex was disrupted of Start (Lanker et al., 1996) . Several proteins have been by elution with 1 M NaCl, suggesting that it depends implicated in Cln instability, including Cdc34 (Deshaies upon charged interactions (Sopta et al., 1985) . In conet al., 1995), Skp1 (Bai et al., 1996) , and a leucine-rich trast, the interaction between Cln2 and Cdc28 was starepeat protein, Grr1 (Barral et al., 1995) . It has been ble to 1 M NaCl, but was disrupted by 1% SDS (Figproposed HA > plasmid (pCB1317) were chromatographed on an analytical scale 12CA5 antibody column. The column was washed with 0.1 M NaCl in affinity column buffer (ACB; wash), and retained proteins were eluted with 1 M NaCl in ACB (NaCl), 1% SDS in ACB (SDS), and 100 mM triethylamine (TEA). Eluted proteins were immunoblotted with 12CA5 antibody, anti-Cdc28 antibody, and anti-Cdc53 antibody.
presence of excess competing HA peptide, or carried retards proliferation of a cdc34 strain (Deshaies et al., 1995) . We found that overexpression of CLN2 or CLN3 out in the absence of 12CA5 antibody ( Figure 2A , lanes 1-3, 5, and 6). As expected, immunoprecipitation of in a cdc53-1 strain impaired colony formation at 30ЊC ( Figure 2C ). In contrast, CLN1 overexpression failed to Cdc53 MYC also specifically coprecipitated Cln2 HA (see below). Comparison to total Cdc53 in cell lysates indicated enhance the cdc53-1 phenotype at 30ЊC, consistent with the weaker interaction between Cln1 and Cdc53. Surthat approximately 1% of total cellular Cdc53 coimmunoprecipitated with Cln2.
prisingly, when CLN3-1 was overexpressed, the cdc53-1 strain was viable at 30ЊC, despite the fact that Cln3-1 To determine whether other yeast cyclin complexes also contained Cdc53, we coexpressed HA-tagged verhyperactivates Start and has 10-to 100-fold more associated kinase activity in vitro than Cln3 (Tyers et al., sions of each of the three G1 cyclins, the S phase cyclin Clb5, and the G2/M phase cyclin Clb2 with a functional 1992). This suggested that the carboxy-terminal region of Cln3, and presumably also Cln2, specifically interCdc53 protein tagged with six tandemly repeated copies of the MYC epitope (referred to as Cdc53 MYC ). In coimmufered with Cdc53 function (see below). The ability of a cdc53-1 strain to form colonies at 30ЊC was not affected noprecipitation experiments, Cdc53
MYC interacted specifically with all three G1 cyclins, but not with either by overexpression of either CLB5 or CLB2 (data not shown). B-type cyclin ( Figure 2B ). As a control, Cdc28 was detected in each of the cyclin immunoprecipitates (Figure 2B Figure 3A , lanes 3 and 5). The inability of Cln3-1 and Cdc53 to form a complex provides a possible explanation for the absence of a genetic interaction between CLN3-1 overexpression and the cdc53-1 mutation.
To examine further the role of the carboxy-terminal domain of Cln2 in the Cln2-Cdc53 interaction, we evaluated the capacity of Cdc53 to interact with Cln2
, a mutant in which all seven Cdc28 consensus phosphorylation sites in the carboxy-terminal region of Cln2 are converted to alanine. Although Cln2 4T3S still binds and activates Cdc28, it is underphosphorylated in vivo and is approximately 8-fold more stable than wild-type Cln2 and results in a constellation of phenotypes characteristic of G1 cyclin hyperactivation (Lanker et al., 1996) . We found that coimmunoprecipitation of Cdc53 MYC with Cln2 4T3S was dramatically reduced relative to wild-type Cln2 ( Figure 3A , lane 7).
The failure of Cdc53 to interact with Cln2 4T3S suggests that phosphorylation of Cln2 is important for the interaction. We extended this correlation by determining that only hyperphosphorylated Cln2 was present in Cdc53 coimmunoprecipitates ( Figure 3B , lane 4). Conversely, hypophosphorylated Cln2 accumulated in cells arrested by the cdc28-4 mutation failed to complex with Cdc53 ( Figure 3B , lane 7). We have also detected a specific interaction between Cdc53 from yeast extracts and hyperphosphorylated forms of Cln2 immobilized on a filter after resolution by SDS-PAGE (data not shown).
To test directly the role of phosphorylation in Cln2-Cdc53 complex formation, we established that Cdc53 To establish a role for Cdc53 in Cln degradation directly, we compared the half-life of Cln2 in a wild-type strain with its half-life in a temperature-sensitive cdc53-1 establish whether Cln-Cdc53 complex formation correlated with Cln instability, we analyzed the interaction strain. For comparison, we also examined Cln2 half-life in a cdc34-2 strain, which stabilizes Cln2 in some strain of Cdc53 with the stable carboxy-terminal truncation , and cdc34 (MTY777) strains were incubated at 37ЊC for 2 hr, after which pGAL1-CLN2 HA was induced for 1.5 hr and then repressed by glucose treatment for the indicated times. Samples were analyzed for Cln2
HA and CLN2 mRNA; equal loading for immunoblots and Northern blots was confirmed by detection with anti-Cdc28 antibody and ACT1, respectively. For accurate representation of Cln2 HA decay rates, exposure times (indicated under each panel) were adjusted to give equal Cln2 HA signals at the 0 min timepoint to compensate for the elevated abundance of Cln2 HA in cdc34 and cdc53 strains. (B) Cdc53-dependent Cln2 instability does not depend on the cdc53 arrest point. A similar experiment was carried out as in (A), except that cultures were first prearrested with 200 mM hydroxyurea for 1.5 hr at 25ЊC before shifting to 37ЊC.
backgrounds (Deshaies et al., 1995 ; see also Salama et al., 1994) . Cln2 half-life was determined in promoter 8) . Exposure of the cdc28-4 Cln2 HA panel (lanes 5-8) was 60 times longer than the wild-type panel to (Salama et al., 1994) . To confirm this, we determined account for the greatly reduced synthesis of Cln2 HA in the cdc28-4
Cln2 half-life in cdc53-1 cells that were prearrested in culture.
S phase by hydroxyurea prior to shifting to the restrictive throughout the cell cycle.
Cln2 Ubiquitination In Vivo Depends on Cln2 Phosphorylation and Cdc53 Function
Since both Cdc53 and Cdc34 are implicated in a ubiquitin-dependent proteolytic pathway, we sought to establish whether Cln2 was ubiquitinated in vivo and, if so, whether this depended on Cln2 phosphorylation. Although Cln2 ubiquitination has been demonstrated in vitro in yeast extracts (Deshaies et al., 1995) , Clnubiquitin conjugates have not previously been detected in vivo. To enhance our ability to detect such conjugates, we utilized cells expressing a polyhistidine-and MYCtagged K48R, G76A mutant ubiquitin (Ubi HIS-MYC-RA ). The K48R mutation prevents the formation of multiubiquitin chains required for recognition by the proteolytic machinery (Chau et al., 1989) , while the G76A mutation inhibits the action of ubiquitin hydrolases that remove ubiquitin from protein-ubiquitin conjugates (Hodgins et al., 1992) . Expression of the Ubi HIS-MYC-RA results in accumulation of monoubiquitinated target proteins, which can be isolated by retention on a Ni 2ϩ -NTA agarose conjugates in the cell lysate ( Figure 5A , lane 4 The dependence of Cln2 ubiquitination on phosphory- conjugates were observed in lysates from either cdc34-2 or cdc53-1 arrested cells ( Figure 5B , lanes 6 and 9). This was despite the fact that Cln2 accumulated to a much investigated the nature of the two electrophoretic forms higher level in the mutants relative to wild-type cells of Cdc53. Since neither phosphorylation nor proteolytic (see Figure 5B , legend). Although nonubiquitinated Cln2 processing could account for the two isoforms (data not in extracts made from cells grown at 37ЊC was retained shown), we determined whether Cdc53 was ubiquition the Ni 2ϩ -NTA resin, this binding was nonspecific, nated. Various tagged versions of Cdc53 were immunosince it did not depend on the polyhistidine tag (Figure precipitated from cell lysates with 9E10 antibody and 5B, lanes 2, 5, and 8). Thus, Cdc53, along with Cdc34, immunoblotted with a polyclonal anti-ubiquitin antiis required for ubiquitination of Cln2 in vivo.
body. A ubiquitinated species corresponding in size to the lower mobility form of Cdc53 was specifically deCdc53 Is Ubiquitinated and Interacts with Cdc34 tected in Cdc53 MYC immunoprecipitates ( Figure 6A ). The The physical interaction between Cdc53 and Clns, along extent of the mobility shift caused by ubiquitination of with the requirement for both Cdc53 and Cdc34 to ubiCdc53 was consistent with modification by a single ubiquitinate Cln2, suggests that Cdc53 may be an E3 ubiquitin moiety (Chau et al., 1989) . The presence of additional MYC epitopes on Cdc53 shifted the mobility of the quitin-protein ligase. To characterize Cdc53 further, we Cdc34-Cdc53 interaction in vitro with recombinant Cdc53 MYC expressed in insect cells and recombinant Cdc34 purified from bacteria. Bacterial Cdc34 added to insect cell lysates was efficiently coimmunoprecipitated from the lysates with Cdc53 MYC ( Figure 6C ). By comparison with known amounts of bacterial Cdc34, we estimate that approximately 4% of the input Cdc34 formed a complex with Cdc53. Although the involvement of insect cell proteins cannot be rigorously excluded, relatively few endogenous proteins would be present in sufficient abundance to mediate the extent of the Cdc34-Cdc53 interaction we observed. Thus, we conclude from these experiments that Cdc34 and Cdc53 directly interact to form a ubiquitin-protein ligase complex.
Discussion

Cdc53 Targets Phosphorylated Clns for Degradation by the Ubiquitin Pathway
We have found that Cdc53 forms a complex with each of the G1 cyclins Cln1, Cln2, and Cln3. Several lines of evidence suggest that the Cln-Cdc53 interaction mediates Cln degradation: Cdc53 interacts specifically with Clns and not with other cyclins; stabilized versions of Cdc28-dependent phosphorylation of specific residues in the Cln carboxyl terminus serves as a conditional determinant for recognition by Cdc53. Once complexed ubiquitinated species, demonstrating that it was derived with Cdc53, and probably with Cdc34, the phosphoryfrom Cdc53 and not from a protein that coimmunoprecilated Cln is ubiquitinated and subsequently degraded pitated with Cdc53. Since the Cdc53-ubiquitin conjuby the ubiquitin proteolytic pathway. This degradative gate was unaffected by harsh reducing conditions in mechanism serves to render the Cln-Cdc28 kinase comprotein sample buffer, it is unlikely the ubiquitin is thioesplexes highly unstable and therefore responsive to terified, and it probably does not represent a catalytic changes in rates of Cln synthesis, as dictated by the intermediate. However, some members of the HECT environmental cues that modulate Start. class of E3 enzymes also form ubiquitin conjugates that are resistant to reducing conditions (Huibregtse et al., 1995) .
Is Cdc53 an E3 Ubiquitin-Protein Ligase? Selective protein degradation by the ubiquitin pathway A role for Cdc53 as an E3 ubiquitin-protein ligase was directly supported by detection of a physical interaction often requires substrate recognition by an E3 ubiquitinprotein ligase (reviewed by Hochstrasser, 1995) . E3 enbetween Cdc53 and Cdc34. Initially, we detected coelution of Cdc34 with Cdc53 from the 12CA5 immunoaffinity zymes can directly participate in the catalytic cascade of ubiquitin transferase reactions columns described in Figure 1 (data not shown) . We also detected a specific interaction between Cdc34 and and often reside in multiprotein complexes. For example, the E3 for the N-end rule pathway forms a complex Cdc53 MYC in coimmunoprecipitation experiments from yeast lysates ( Figure 6B ). Finally, we reproduced the with its cognate E2 and with other proteins (Madura et al., 1993) . Cdc53 fulfills important criteria for an E3 a stable complex with its cognate E2 enzyme Cdc34. More strikingly, activity of the APC is regulated by Cdc2-ubiquitin-protein ligase as it interacts with both the Cln substrate and the E2 enzyme Cdc34. In addition to these dependent phosphorylation , whereas the Cdc53-dependent degradation of Clns is essential protein-protein interactions, Cdc53 is stably conjugated to ubiquitin, a characteristic shared by some constitutive throughout the cell cycle and is regulated at the substrate level by phosphorylation. HECT domain E3 ubiquitin-protein ligases (Huibregtse et al., 1995) . It is noteworthy that Cdc53 homologs have G1 cyclin activity is rate limiting for cell division in yeast, flies, and mammals (reviewed by Sherr, 1994) recently been identified in a number of species from yeasts to humans (Mathias et al., submitted; Kipreos et and often contributes to tumor progression in human cancers (reviewed by Hunter and Pines, 1994) . Recently, al., 1996) , and thus Cdc53 may define a novel class of E3 ubiquitin-protein ligases.
Cdc53 homologs have been identified in a number of species, including humans (Mathias et al., submitted; We have not yet been able to detect ubiquitin-protein ligase activity toward Cln substrates with recombinant Kipreos et al., 1996) . The potential importance of these proteins in regulation of cell division in other organisms Cdc34 and Cdc53 produced in insect cells. This could reflect the fact that the Cdc53 complex in yeast may is underscored by the finding that the Cdc53 homolog encoded by the cul-1 (lin-19) gene in Caenorhabditis contain other proteins essential for substrate recognition. For instance, Cdc4 forms a complex with Cdc53 elegans acts to restrain inappropriate cell proliferation during development (Kipreos et al., 1996) . Although the (Mathias et al., submitted; our unpublished data) and could conceivably facilitate Cdc53-substrate interacinvolvement of Cdc53 homologs in G1 cyclin degredation in metazoans has yet to be established, it is tempttions through its WD-40 repeat motifs (Yochem and Byers, 1987) . Skp1, which is necessary for Cln2 instability ing to speculate that these proteins may act as tumor suppressors. and binds directly to Cdc4 (Bai et al., 1996) , is another possible component of the Cdc53 complex. Finally, Grr1, which is required for instability of Cln1 and Cln2
Experimental Procedures (Barral et al., 1995) , may also participate in the Cdc53-
Plasmids and Yeast Strains
Cln interaction. Intriguingly, both Cdc4 and Grr1 contain Plasmids are listed in Table 1 . A 3.6 kb EcoRI fragment (Mathias et a novel motif first identified in cyclin F, called the F-box; al., submitted) containing the CDC53 gene and 600 bp of upstream this motif is essential for the interaction of Cdc4 with promoter sequence was cloned into pRS314 and pRS424 (Sikorski Skp1 (Bai et al., 1996) . Definition of the role these proand Hieter, 1989). To epitope tag Cdc53 at the amino terminus, teins play in Cln recognition and ubiquitination awaits artificial BamHI and NdeI sites were placed at the 5Ј end of the CDC53 coding region by site-directed mutagenesis, and a tandem further biochemical characterization of the Cdc53 triple MYC epitope (Schneider et al., 1995) was inserted into the complex. strains by stabilization of p40 SIC1 , which causes cell cycle (Hadwiger et al., 1989b) and CLN2 T (Salama et al., 1994) was made arrest prior to DNA replication (Schwob et al., 1994) .
by placing a NotI site followed by a termination codon at nucleotide Like Cln degradation, p40 SIC1 degradation depends on position 1132 of CLN2 and inserting a triple HA epitope (Tyers et phosphorylation by the Cln-Cdc28 kinases (Schwob et al., 1992) . We refer to this allele as CLN2-1 HA . All mutagenized regions al., 1994; Schneider et al., 1996; Tyers, 1996) , suggesting were completely sequenced to ensure random mutations did not arise during mutagenesis.
that phosphorylation may trigger degradation of all subYeast strains are listed in (McKinney et al., 1993; Kornitzer et al., 1994; Yoon and 1994) . All carbon sources were used at 2% w/v. For induction of Carbon, 1995) . It will be of interest to determine whether pGAL1 expression constructs, strains were grown to a density of 0.5 ϫ 10 7 to 1.0 ϫ 10 7 cells per milliliter in raffinose and induced degradation of these proteins requires Cdc53 function.
with galactose for 2 hr.
Immunoaffinity Column Chromatography
Conserved Proteolytic Mechanisms of Cell
A preparative scale anti-HA antibody column was made by cross-
Cycle Regulation
linking IgG from 1-2 ml of 12CA5 ascites fluid (approximately 10
The APC is a conserved ubiquitin-protein ligase that mg/ml total IgG) to a 1 ml volume of protein A beads with dimethylcatalyzes ubiquitination of mitotic cyclins and probably suberimidate (Harlow and Lane, 1988) . Lysates were made from other proteins (reviewed by Murray, 1995) . We have pro<pADH1-CLN2 HA > cdc34-2 cells that had been arrested at 37ЊC for 4-6 hr at a density of 2 ϫ 10 7 cells per milliliter in batches of 25 l.
vided evidence that Cdc53 fulfills an analogous function Cell pellets were resuspended in an equal volume of buffer 3 plus in G1 cyclin degradation at Start. Like the APC, the protease inhibitors (Tyers et al., 1993) and lysed by grinding with Cdc34-Cdc53 complex probably has multiple targets, glass beads in a bead beater that was cooled by an ice water bath.
including the Clns and p40
SIC1
. However, unlike the APC, which is chromatographically separable from the E2 acwas clarified by centrifugation at 100,000 ϫ g for 1 hr and then tivity required for cyclin ubiquitination (King et al., 1995;  passed over a 12CA5 column by gravity flow at 4ЊC. Columns were washed with 10-20 ml of buffer 3, and bound proteins were eluted Sudakin et al., 1995) , we have found that Cdc53 forms with 100 mM triethylamine. Control untagged column eluates were gel with 50% acetonitrile and separated by HPLC on a Vydac C18 column (1.0 ϫ 250 mm, 10 m, 300 Å ). Each peptide was sequenced generated from a starting culture that lacked the <pADH1-CLN2
HA > plasmid. Analytical scale immunoaffinity columns were performed by automated protein sequencers (Applied Biosystems models 470, 473, and 477). For p94, 11 peptides corresponded to the deduced in a similar manner, with the exceptions that cell lysates were prepared by grinding frozen cell pellets in liquid nitrogen (Schultz et Cdc53 sequence, two peptides (LTDSLVQRAG; DLMLYVSK) corresponded to yeast EF-2 sequence, and one peptide (YQPAALIAal., 1991) and affinity column buffer was used for cell lysis and column elution (Sopta et al., 1985) . GEERK) did not match any known sequence.
Protein and RNA Analysis Protein Sequencing
Proteins in preparative scale column fractions were separated by Immunoprecipitations and immunoblots were processed for ECL (Amersham) detection as described previously (Tyers et al., 1993) , SDS-PAGE and detected by staining with high purity Coomassie brilliant blue (Sigma, . Protein bands were excised from the except that cell lysates were made by grinding in liquid nitrogen (Schultz et al., 1991) . RNA was isolated and analyzed as described gel, washed twice with 50% methanol, and digested with 500 ng of Achromobacter protease I in 0.1% Tween 20, 0.1 M Tris-HCl (pH previously (Tyers et al., 1993) . Affinity-purified antibodies against Cdc53 and Cdc34 (Mathias et al., submitted), crude anti-Cdc28 9.0) for 20 hr at 30ЊC. Peptide fragments were extracted from the 
